Company name: Aphria (Arizona)
Description: Producer of medical cannabis. The company’s products include medically prescribed marijuana, enabling patients to treat cancer by reducing nausea and vomiting during chemotherapy, improve appetite in people.
Industry: Materials and Resources | Group: Agriculture | Code:
Start up capital raised (USD Million):
Business status: Generating Revenue
Revenue (USD Million):
Gross profit (USD Million):
Net income (USD Million)
Earnings before interest, tax, depreciation and amortization (EBITDA):
Financing Status: The company, a subsidiary of Aphria was acquired by Liberty Health Sciences (CNQ: LHS) for USD 20 million in June 2018. The acquisition further demonstrates acquirer’s commitment to expanding its leadership position in the U.S. medical cannabis industry.
Number of active investors:
Profile last updated: 12-Oct-2018
Last known valuation: 20.00
Last known valuation date: 30-Jun-2018